Not Tagged
bms
['bms']
big news - turning point therapeutics (tpx-005, repotrectinib) acquired for $4.1 billion by bms, announced with #asco22. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him